Moshe Phillip

Active 1988–2025

129
Papers
21,651
Citations
78
h-index
118
i10-index

Citations

Citations per year for Moshe Phillip1982: 1 citations1991: 1 citations1992: 1 citations1993: 3 citations1994: 1 citations1995: 2 citations1996: 1 citations1997: 3 citations1998: 5 citations1999: 10 citations2000: 23 citations2001: 15 citations2002: 27 citations2003: 23 citations2004: 57 citations2005: 41 citations2006: 56 citations2007: 66 citations2008: 76 citations2009: 102 citations2010: 76 citations2011: 104 citations2012: 89 citations2013: 107 citations2014: 138 citations2015: 106 citations2016: 120 citations2017: 112 citations2018: 192 citations2019: 568 citations2020: 748 citations2021: 821 citations2022: 715 citations2023: 676 citations2024: 1,041 citations2025: 518 citations2026: 27 citations1983–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,942 citing papers, 23.5% of this breakdownUnited Kingdom: 696 citing papers, 8.4% of this breakdownItaly: 519 citing papers, 6.3% of this breakdownGermany: 380 citing papers, 4.6% of this breakdownChina: 343 citing papers, 4.2% of this breakdownAustralia: 336 citing papers, 4.1% of this breakdownCanada: 292 citing papers, 3.5% of this breakdownDenmark: 260 citing papers, 3.2% of this breakdownFrance: 243 citing papers, 2.9% of this breakdownSpain: 221 citing papers, 2.7% of this breakdownNetherlands: 199 citing papers, 2.4% of this breakdownSweden: 199 citing papers, 2.4% of this breakdown
0%23.5%Other 31.8%

Fields

  • Medicine82.6%
  • Biochemistry, Genetics and Molecular Biology8.4%
  • Neuroscience1.7%
  • Health Professions1.7%
  • Nursing1.1%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Other3.4%

Topics

  • Diabetes Management and Research19.7%
  • Pancreatic function and diabetes9.9%
  • Diabetes and associated disorders9.3%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients6.1%
  • Diabetes Treatment and Management5.2%
  • Diabetes Management and Education2.4%
  • Other47.4%

Coauthors

All papers

Open in search
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 cited by 3,797

  2. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E Umpierrez, Stuart A. Weinzimer, Moshe Phillip - The Lancet Diabetes & Endocrinology 2022 cited by 725

  3. International Consensus on Use of Continuous Glucose Monitoring

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2017 cited by 2,026

  4. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 cited by 402

  5. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev - Journal of Diabetes Science and Technology 2022 cited by 276

  6. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 328

  7. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 cited by 237

  8. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeppe Gram, Claus Bogh Juhl, Janne Hukkanen, Jorma Lahtela, Leo Niskanen, Donal O’Shea, Timothy O’Brien, Séamus Sreenan, Julio Wainstein, Moshe Phillip, Hilla Knobler, Francesco Dotta, Pier Marco Piatti, Roberto Trevisan, Agostino Gnasso, Hanne L. Gulseth, John Cooper, Ewa Pańkowska, Monika Łukaszewicz, Bogumił Wolnik, Isabel Manita, Olinda Marques, Cristina Roque, Rosa Maria Príncipe, Celestino Neves, Susana Heitor, L. A. Ruyatkina, I. V. Dvoryashina, Gulnar Vagapova, Lidiya Belousova, M. Sergeeva-Kondrachenko, А. Б. Песков, Elena Frolova, Albina Golovach, М. А. Куницына, N Krasnopeeva, Irina Ipatko, Carmen De la Cuesta, Francisco J. Tinahones, Mercedes Rigla, Juan Francisco Merino-Torres, Luis Alberto Gómez, Mercè Fernández, Rafael Simó, Mikael Rydén, Johan Jendle, Karin Filipsson, Björn Eliasson, Borys Mankovsky, Iurii Lymar, Liubov Sokolova, Galyna Myshanych, Tetiana Zlova, М.V. Vlasenkо, Petro Kuskalo -, Hamish Courtney, Colin Dayan, Patrick English, Simon Heller, A.B. Johnson, Sunil Nair, Richard David Leslie, Parth Narendran, Nick Oliver, Shenaz Ramtoola, J. H. F. Shaw, Adie Viljoen, Amer Al‐Karadsheh, Jean M. Dostou, Sumana Gangi and 13 more - The Lancet Diabetes & Endocrinology 2021 cited by 178

  9. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2019 cited by 356

  10. Glycaemic management in diabetes: old and new approaches

    Authors: , , , , , - The Lancet Diabetes & Endocrinology 2021 cited by 129

  11. Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetes Care 2024 cited by 68

  12. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Thomas Schaum, Diethelm Tschoepe, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban, Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro, Stobschinski de Alba, Carlos Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández and 70 more - The Lancet Diabetes & Endocrinology 2017 cited by 292

  13. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

    Authors: , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2022 cited by 102

  14. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Diethelm Tschöpe, Thomas Schaum, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro Stobschinski de Alba, Carlos Eduardo Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández, Roberto Araujo Silva, Efraín Villeda-Espinosa and 68 more - Diabetes Care 2018 cited by 238

  15. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetologia 2024 cited by 58

  16. Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

    Authors: , , , , , - Diabetes Care 2011 cited by 491

  17. Short and tall stature: a new paradigm emerges

    Authors: , , , , , , - Nature Reviews Endocrinology 2015 cited by 319

  18. The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

    Authors: , , , , , , , , , , , - Diabetes Technology & Therapeutics 2020 cited by 143

  19. Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives

    Authors: , , , , , , , , , , , , , , , - Diabetes Technology & Therapeutics 2021 cited by 56

  20. Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

    Authors: , , , , , , , - Diabetes Care 2006 cited by 544

  21. MD-Logic Artificial Pancreas System

    Authors: , , , , - Diabetes Care 2010 cited by 264

  22. Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials

    Authors: , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 cited by 78

  23. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Danne, Eran Atlas, Moshe Phillip - Diabetes Obesity and Metabolism 2018 cited by 78

  24. Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT ‐1 and ‐2 studies

    Authors: , , , , , , , , , , , , , , - Diabetes Obesity and Metabolism 2020 cited by 40